Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation: a meta-analysis

Colleen L Jay1, Vadim Lyuksemburg, Daniela P Ladner

  • 1Comprehensive Transplant Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.

Annals of Surgery
|January 20, 2011
PubMed

Insights

Donation after cardiac death liver transplantation is associated with significantly higher risks of biliary complications, including ischemic cholangiopathy, and worse patient outcomes compared to donation after brain death. These findings highlight critical considerations for graft utilization and patient care.

Area of Science:

  • Hepatology
  • Transplantation Surgery
  • Gastroenterology

Background:

  • Biliary complications pose significant health and economic challenges in liver transplantation.
  • Understanding these risks is crucial for improving patient outcomes.

Purpose of the Study:

  • To compare the risks of biliary complications, particularly ischemic cholangiopathy (IC), after liver transplantation from donation after cardiac death (DCD) versus donation after brain death (DBD) donors.
  • To enhance the understanding of outcomes associated with DCD liver transplantation.

Main Methods:

  • A meta-analysis was performed using data from MEDLINE, EMBASE, and Cochrane Library databases.
  • Eleven retrospective cohort studies involving 489 DCD and 4455 DBD liver transplant recipients were included.
  • Odds ratios (OR) and 95% confidence intervals (CI) were calculated using random effects models.

Main Results:

  • Donation after cardiac death recipients had a 2.4-fold increased odds of biliary complications and a 10.8-fold increased odds of IC.
  • Ischemic cholangiopathy occurred in 16% of DCD recipients versus 3% of DBD recipients.
  • DCD recipients also showed higher odds of 1-year mortality and graft failure.

Conclusions:

  • Donation after cardiac death liver transplantation is linked to inferior outcomes, including higher rates of biliary complications and IC.
  • Increased mortality and graft failure rates are observed in DCD recipients.
  • The elevated risks and poor outcomes necessitate careful consideration of DCD graft utilization.
Abstract